Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: BangladesFázis nélkül

Post-stroke Nurse-led Rehabilitation to Improve Functional Activity and Community Participation in Bangladesh

A legfontosabb adatok

Hol
Dhaka (Banglades)A helyszín megnézése

AI-kivonat: kiket keres a vizsgálat

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

A vizsgálat olyan felnőtteket keres, akik stroke-on estek át, és egy karjuk vagy lábuk mozgása korlátozott. Egy 6 hónapos, ápolók által vezetett rehabilitációs programot vizsgál Bangladesben.

Életkor
18 éves vagy idősebb
Nem
Férfiak és nők is részt vehetnek
A betegség stádiuma
Bármilyen típusú stroke, a stroke óta eltelt idő nem számít. Fogyatékossági pontszám (mRS) 2-4, a kar és/vagy a láb mozgáskorlátozottságával.
Korábbi kezelés
Az orvos rehabilitációt javasolt, és a személynek segédeszközre van szüksége a mindennapi tevékenységekhez. A személy nem tervezhet intézményi rehabilitációs szolgáltatást igénybe venni.

A részvétel fő kizáró okai

  • Részvétel más klinikai vizsgálatokban
  • Intézményi rehabilitációs szolgáltatás tervezett igénybevétele
  • Nem tud kommunikálni (beszédzavara van)
  • Nincs telefonja

Gépi kiolvasás: 2026. november 12.

Helyszínek itt: Banglades

  • National Institute of Neuroscience and HospitalDhaka, BangladesContact: Md. Abdullah Yusuf, MBBS, MDRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Hiroshima University
Azonosító
NCT07384650
A regiszteradat frissítve
2026. április 7.
Eredeti leírás
Stroke causes various levels of disability which decreases physical function for a prolonged period. The purpose of this study is to evaluate the effectiveness of a nurse-led rehabilitation program including a multidisciplinary team focused on improving the functional ability among post-stroke patients in Bangladesh. A prospective, open-label (1:1) randomized controlled trial (RCT) will be conducted at the National Institute of Neuroscience \& Hospital (NINS\&H) in Dhaka, Bangladesh from January 2026 to September 2026. Participants will be the post-stroke patients who got discharged from NINS\&H within 2 weeks after the onset of stroke and the family caregivers of the patients and meet the inclusion criteria. The sample size will be calculated based on G-Power analysis with a medium effect size and will be 166. The intervention will be designed to provide the 6-months Nurse-led rehabilitation program including a multidisciplinary team regarding self-care and the use of assistive devices. Assessment for rehabilitation will be performed by the multidisciplinary team with research nurses (RA nurses), physiotherapists (PT) and occupational therapists (OT). The control group will receive the usual care. The primary outcome is improved activity and participation measured by the Functional Independence Measurement (FIM). The secondary outcomes are improved motor function, self-efficacy, emotional status and participation ability. The endpoints will be compared at baseline, 3rd and 6th months. We assume that patients receiving rehabilitation education and assistive device progress to achieve an optimal level of independence, with improved motor function, emotional status and participation ability to re-integrate into society.A teljes eredeti leírásKevesebb

Post-discharge Nurse-led Rehabilitation to Improve Functional Activity and Community Participation Among Stroke-Patients in Bangladesh: A Randomized Controlled Trial

Stroke causes various levels of disability which decreases physical function for a prolonged period. The purpose of this study is to evaluate the effectiveness of a nurse-led rehabilitation program including a multidisciplinary team focused on improving the functional ability among post-stroke patients in Bangladesh. A prospective, open-label (1:1) randomized controlled trial (RCT) will be conducted at the National Institute of Neuroscience \& Hospital (NINS\&H) in Dhaka, Bangladesh from January 2026 to September 2026. Participants will be the post-stroke patients who got discharged from NINS\&H within 2 weeks after the onset of stroke and the family caregivers of the patients and meet the inclusion criteria. The sample size will be calculated based on G-Power analysis with a medium effect size and will be 166. The intervention will be designed to provide the 6-months Nurse-led rehabilitation program including a multidisciplinary team regarding self-care and the use of assistive devices. Assessment for rehabilitation will be performed by the multidisciplinary team with research nurses (RA nurses), physiotherapists (PT) and occupational therapists (OT). The control group will receive the usual care. The primary outcome is improved activity and participation measured by the Functional Independence Measurement (FIM). The secondary outcomes are improved motor function, self-efficacy, emotional status and participation ability. The endpoints will be compared at baseline, 3rd and 6th months. We assume that patients receiving rehabilitation education and assistive device progress to achieve an optimal level of independence, with improved motor function, emotional status and participation ability to re-integrate into society.

Bevonási feltételek: 18 years old and above, both males \& females,; Irrespective of the type of stroke and time of stroke,; mRS 2-4 with disability on upper and/or lower limb(s); Physician advice on rehabilitation, and who needs assistive devices for ADL,; Having a phone, and; Willing to provide consent \& participate in the study.

Kizáró feltételek: Participation in other clinical trials,; Planning to receive institutional rehabilitation services, and; Cannot communicate (having speech difficulties).

ClinicalTrials.gov NCT07384650